Predictive effect of DCE-MRI and DWI in brain metastases from NSCLC

Predictive effect of DCE-MRI and DWI in brain metastases from NSCLC

Non-small cell lung cancer (NSCLC), a commonly diagnosed lung cancer, is characterized by a high incidence of metastatic spread to the brain, which adversely impacts prognosis. The present study aimed to assess the value of combined dynamic contrast-enhanced MRI (DCE-MRI) and diffusion-weighted imag...

Full description

Bibliographic Details
Main Authors:	Ye Chengyu, Lin Quanbing, Jin Zhang, Zheng Cuiping, Ma Shenglin
Format:	Article
Language:	English
Published:	De Gruyter 2021-08-01
Series:	Open Medicine
Subjects:	dynamic contrast-enhanced mri diffusion-weighted imaging non-small cell lung cancer brain metastasis whole-brain radiotherapy gefitinib
Online Access:	https://doi.org/10.1515/med-2021-0260

Similar Items

Can DWI-MRI be an alternative to DCE-MRI in the diagnosis of troublesome breast lesions?
by: Lamiaa Mohamed Bassam Hashem, et al.
Published: (2021-05-01)

Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer
by: R.F. Yang, et al.
Published: (2017-11-01)

DCE-MRI is more sensitive than IVIM-DWI for assessing anti-angiogenic treatment-induced changes in colorectal liver metastases
by: Mihaela Rata, et al.
Published: (2021-12-01)

Diagnostic value of DWI-MRI for the detection of acute plaques in the relapse phase of multiple sclerosis
by: Mehran Yousefi, et al.
Published: (2021-03-01)

Role of Diffusion-Weighted and Contrast Enhanced MRI Brain in the Evaluation of Paediatric Epilepsy
by: Ghada M. Abdelrazek, et al.
Published: (2024-01-01)

Clinical Experience of Gefitinib in the Treatment of 32 Lung Adenocarcinoma Patients with Brain Metastases
by: Jianping XU, et al.
Published: (2015-09-01)

Distribution of brain metastases: low-risk metastasis areas may be avoided when treating with whole-brain radiotherapy
by: Binwei Lin, et al.
Published: (2020-04-01)

Comparative study of imaging and histology of sacroiliac joint in normal rats based on IVIM-DWI and DCE-MRI
by: Jian Qin, et al.
Published: (2020-07-01)

Frequency of metastases within the hypothalamic–pituitary area and the associated high-risk factors in patients with brain metastases
by: Peng Xie, et al.
Published: (2023-11-01)

A phase II study of anlotinib plus whole brain radiation therapy for patients with NSCLC with multiple brain metastases
by: Dayong Gu, et al.
Published: (2024-12-01)

Role of DCE and DWI in Differentiating between Benign and Malignant Breast Masses using 3T MRI: A Cross-sectional Study
by: A Pavithra, et al.
Published: (2023-03-01)

Blood–brain barrier and brain structural changes in lung cancer patients with non-brain metastases
by: Da-Fu Zhang, et al.
Published: (2022-10-01)

Time-Efficient Perfusion Imaging Using DCE- and DSC-MRI
by: Macíček Ondřej, et al.
Published: (2018-10-01)

GEFITINIB (IRESSA) IN THE TREATMENT OF BRAIN METASTASES FROM NON-SMALL CELL LUNG CARCINOMA
by: D. R. Naskhletashvili, et al.
Published: (2015-04-01)

Near Total Regression of Diffuse Brain Metastases in Adenocarcinoma of the Lung with an EGFR Exon 19 Mutation: A Case Report and Review of the Literature
by: Wen-Hao Tang, et al.
Published: (2011-09-01)

Evaluation of Solid Brain Metastases in Lung Cancers with Diffusion MRI [Akciger Kanserli Hastalarda Solid Beyin Metastazlarinin Difuzyon MRG ile Degerlendirilmesi]
by: Ismail Okan Yildirim, et al.
Published: (2014-03-01)

DCE-MRI and DWI can differentiate benign from malignant prostate tumors when serum PSA is ≥10 ng/ml
by: Hongmei Sun, et al.
Published: (2022-12-01)

The value of CESM in the evaluation of intraductal breast papilloma: a comparative study with DCE-MRI
by: Rania Hegazy, et al.
Published: (2020-02-01)

Comparison of clinical and MRI features of brain metastases between ALK+ and ALK‐ NSCLC
by: Xiaolu Ren, et al.
Published: (2024-06-01)

The Expanding Role of Radiosurgery for Brain Metastases
by: Mark O’Beirn, et al.
Published: (2018-08-01)

The significance of PI-RADS v2.1 score combined with quantitative parameters of DWI and DCE-MRI in differentiating between benign prostatic hyperplasia and prostate cancer
by: Chengcheng Gao, et al.
Published: (2024-09-01)

Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases
by: Justin T. Moyers, et al.
Published: (2021-02-01)

The influence of xenon-therapy on tolerance of adjuvant radiotherapy in patients with single brain metastasis
by: M. S. Zinkovich, et al.
Published: (2018-03-01)

Recognition of Brain Metastases Using Gadolinium-Enhanced SWI MRI: Proof-of-Concept Study
by: Joel Ceballos-Ceballos, et al.
Published: (2020-02-01)

Whole Brain Irradiation and Hypo-fractionation Radiotherapy for the Metastases in Non-small Cell Lung Cancer
by: Xingting GU, et al.
Published: (2016-04-01)

Magnetic resonance imaging characteristics of brain metastases in small cell lung cancer
by: Dan Zhu, et al.
Published: (2023-07-01)

Reirradiation of Whole Brain for Recurrent Brain Metastases: A Case Report of Lung Cancer With 12-Year Survival
by: Minmin Li, et al.
Published: (2021-11-01)

DWIBS: Can it replace DCE-MRI in detection and characterization of suspicious breast lesions?
by: Nermeen N. Keriakos, et al.
Published: (2017-12-01)

Untoward global effects of current guideline formulation of stereotactic radiotherapy for symptomatic brain metastases by international medical societies
by: Dorien E.C.M. de Vocht, et al.
Published: (2023-09-01)

Analysis of prognostic factors in patients with brain metastases affecting survival
by: Sweety Gupta, et al.
Published: (2022-11-01)

Longitudinal MRI evaluation of the efficacy of non-enhanced lung cancer brain metastases
by: Xian Zhang, et al.
Published: (2025-01-01)

Breakouts—A Radiological Sign of Poor Prognosis in Patients With Brain Metastases
by: Raquel Blazquez, et al.
Published: (2022-04-01)

Peritumoral Brain Edema in Metastases May Be Related to Glymphatic Dysfunction
by: Cheng Hong Toh, et al.
Published: (2021-10-01)

Computer Tomography Radiomics-Based Nomogram in the Survival Prediction for Brain Metastases From Non-Small Cell Lung Cancer Underwent Whole Brain Radiotherapy
by: Ji Zhang, et al.
Published: (2021-02-01)

The role of magnetic resonance imaging in the management of brain metastases: diagnosis to prognosis
by: Rasheed Zakaria, et al.
Published: (2014-04-01)

The association between graded prognostic assessment and the prognosis of brain metastases after whole brain radiotherapy: a meta-analysis
by: Xiaohan Geng, et al.
Published: (2024-01-01)

Survival outcomes of breast cancer patients with brain metastases: A multicenter retrospective study in Korea (KROG 16–12)
by: Jae Sik Kim, et al.
Published: (2020-02-01)

A Clinical Observation of Concomitant Therapy of Erlotinib and Whole Brain Radiotherapy in Patients of NSCLC Combined with Brain Metastases
by: Lihong ZHANG, et al.
Published: (2009-12-01)

Hypofractionated Radiation Therapy for Large Brain Metastases
by: Giuseppina Laura Masucci
Published: (2018-10-01)

Influence of Signal to Noise Ratio on the Pharmacokinetic Analysis in DCE-MRI Studies
by: Azimeh NV Dehkordi, et al.
Published: (2019-12-01)